Venus Concept IncNASDAQ:VERONASDAQ FSI:D. Deficient (Issuer failed to meet continued listing requirements)
- LAST PRICE0.6843
- TODAY'S CHANGE (%)-0.0846 (-11.0016%)
- Bid / Lots0.6800/ 98
- Ask / Lots0.7400/ 10
- Open / Previous Close0.7330 / 0.7689
- Day Range
- 52 Week Range
- Volume14,321
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | VERO |
|---|---|---|
| 09:32 ET | 183 | 0.733 |
| 10:10 ET | 100 | 0.711 |
| 10:12 ET | 3470 | 0.7048 |
| 10:14 ET | 4673 | 0.6929 |
| 10:15 ET | 304 | 0.69 |
| 10:17 ET | 300 | 0.6843 |
| 10:21 ET | 250 | 0.6843 |
| 10:30 ET | 300 | 0.6843 |
| 10:32 ET | 133 | 0.702 |
| 10:33 ET | 200 | 0.6843 |
| 10:35 ET | 208 | 0.6843 |
| 10:42 ET | 100 | 0.6843 |
| 10:51 ET | 500 | 0.6844 |
| 11:00 ET | 266 | 0.6844 |
| 11:15 ET | 2495 | 0.6843 |
Apr 24, 2024
Venus Concept Announces Loan Purchase and Completion of First Phase of Refinancing, from 4:05PM ET on Wednesday Apr 24, 2024 by Dow Jones
4:05PM ET on Wednesday Apr 24, 2024 by Dow JonesPress Release: Venus Concept Announces Loan Purchase and Completion of First Phase of Refinancing, from 4:05PM ET on Wednesday Apr 24, 2024 by Dow Jones
4:05PM ET on Wednesday Apr 24, 2024 by Dow Jones
Apr 15, 2024
Venus Concept to Release First Quarter of Fiscal Year 2024 Financial Results on May 15, 2024, from 7:30AM ET on Monday Apr 15, 2024 by Dow Jones
7:30AM ET on Monday Apr 15, 2024 by Dow Jones
Apr 8, 2024
Venus Concept Announces Israeli Regulatory Approval for Venus Bliss MAX, from 7:30AM ET on Monday Apr 08, 2024 by Dow Jones
7:30AM ET on Monday Apr 08, 2024 by Dow Jones
Apr 3, 2024
Venus Concept Announces Australian Regulatory Approval for Venus Versa Pro, from 7:30AM ET on Wednesday Apr 03, 2024 by Dow Jones
7:30AM ET on Wednesday Apr 03, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Venus Concept Inc | 4.9M | -0.1x | --- |
Vapotherm Inc | 7.8M | -0.1x | --- |
NantHealth Inc | 11.3M | -0.1x | --- |
Vaso Corp | 49.1M | 8.7x | --- |
Xylo Technologies Ltd | 3.1M | -0.2x | --- |
ETAO International Co Ltd | 15.1M | 0.0x | --- |
Company Information
Venus Concept Inc. is a global medical aesthetic technology company. The Company has a broad product portfolio of minimally invasive and non-invasive medical aesthetic and hair restoration technologies and reaches in over 60 countries and 14 direct markets. The Company's product portfolio consists of aesthetic device platforms, including Venus Versa, Venus Legacy, Venus Velocity, Venus Fiore, Venus Viva, Venus Glow, Venus Bliss, Venus BlissMAX, Venus Epileve, Venus Viva MD and AI.ME. Its hair restoration systems include NeoGraft and the ARTAS iX Robotic Hair Restoration system. The Company's systems are designed on flexible platforms that enable it to expand beyond the aesthetic industry's traditional markets of dermatology and plastic surgery, and into non-traditional markets, including family and general practitioners and aesthetic medical spas. The Company's hair loss treatment solutions include the ARTAS Solution and the NeoGraft Solution.
Contact Information
- Headquarters
- 235 Yorkland Blvd Suite 900TORONTO, ON, Canada M2J 4Y8
- Phone
- 408-883-6888
- Fax
- 302-655-5049
Executives
- Independent Chairman of the Board
- Scott Barry
- President, Chief Operating Officer
- Hemanth Varghese
- Chief Executive Officer, Director
- Rajiv De Silva
- Chief Financial Officer, Executive Vice President
- Domenic Della Penna
- Chief Human Resource Officer
- Anna Georgiadis
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $4.9M |
|---|---|
Revenue (TTM) | $76.4M |
Shares Outstanding | 6.4M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.61 |
EPS | $-6.86 |
Book Value | $-2.54 |
P/E Ratio | -0.1x |
Price/Sales (TTM) | 0.1 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -39.98% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
